Improved prognosis for localized malignant lymphomas of the head and neck

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Improved prognosis for localized malignant lymphomas of the head and neck. / Aanaes, Kasper; Kristensen, Elisabeth; Ralfkiær, Elisabeth M; von Buchwald, Christian; Specht, Lena; Aanaes, Kasper; Kristensen, Elisabeth; Ralfkiaer, Elisabeth M; von Buchwald, Christian; Specht, Lena.

I: Acta Oto-Laryngologica, Bind 130, Nr. 5, 01.05.2010, s. 626-31.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Aanaes, K, Kristensen, E, Ralfkiær, EM, von Buchwald, C, Specht, L, Aanaes, K, Kristensen, E, Ralfkiaer, EM, von Buchwald, C & Specht, L 2010, 'Improved prognosis for localized malignant lymphomas of the head and neck', Acta Oto-Laryngologica, bind 130, nr. 5, s. 626-31. https://doi.org/10.3109/00016480903311229, https://doi.org/10.3109/00016480903311229

APA

Aanaes, K., Kristensen, E., Ralfkiær, E. M., von Buchwald, C., Specht, L., Aanaes, K., Kristensen, E., Ralfkiaer, E. M., von Buchwald, C., & Specht, L. (2010). Improved prognosis for localized malignant lymphomas of the head and neck. Acta Oto-Laryngologica, 130(5), 626-31. https://doi.org/10.3109/00016480903311229, https://doi.org/10.3109/00016480903311229

Vancouver

Aanaes K, Kristensen E, Ralfkiær EM, von Buchwald C, Specht L, Aanaes K o.a. Improved prognosis for localized malignant lymphomas of the head and neck. Acta Oto-Laryngologica. 2010 maj 1;130(5):626-31. https://doi.org/10.3109/00016480903311229, https://doi.org/10.3109/00016480903311229

Author

Aanaes, Kasper ; Kristensen, Elisabeth ; Ralfkiær, Elisabeth M ; von Buchwald, Christian ; Specht, Lena ; Aanaes, Kasper ; Kristensen, Elisabeth ; Ralfkiaer, Elisabeth M ; von Buchwald, Christian ; Specht, Lena. / Improved prognosis for localized malignant lymphomas of the head and neck. I: Acta Oto-Laryngologica. 2010 ; Bind 130, Nr. 5. s. 626-31.

Bibtex

@article{a2775e80485b11df928f000ea68e967b,
title = "Improved prognosis for localized malignant lymphomas of the head and neck",
abstract = "Abstract Conclusion: In this study we found localized malignant lymphomas of the head and neck to be highly treatable and to have a significantly improved prognosis with recent treatment methods. The head and neck surgeon should keep in mind that the prognosis, especially for diffuse large B-cell lymphoma, has improved if the patient receives the optimal treatment. Objectives: The purpose of this study was to ascertain the current prognosis of localized malignant lymphoma of the head and neck given recent advancements in treatment and diagnostic features, as well as adding histological subtypes to the literature according to the 2001 classification. Methods: We present a retrospective study including a cohort of 100 consecutive patients who had localized malignant lymphoma within the head and neck region diagnosed at a single centre from 2000 to 2007. Results: The histology was revised according to the WHO classification and showed 58% with diffuse large B-cell lymphoma. The estimated 5-year overall survival rate was 83%, which should be seen in contrast to survival rates of 40-70% 25 years ago.",
author = "Kasper Aanaes and Elisabeth Kristensen and Ralfki{\ae}r, {Elisabeth M} and {von Buchwald}, Christian and Lena Specht and Kasper Aanaes and Elisabeth Kristensen and Ralfkiaer, {Elisabeth M} and {von Buchwald}, Christian and Lena Specht",
year = "2010",
month = may,
day = "1",
doi = "10.3109/00016480903311229",
language = "English",
volume = "130",
pages = "626--31",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Taylor & Francis",
number = "5",

}

RIS

TY - JOUR

T1 - Improved prognosis for localized malignant lymphomas of the head and neck

AU - Aanaes, Kasper

AU - Kristensen, Elisabeth

AU - Ralfkiær, Elisabeth M

AU - von Buchwald, Christian

AU - Specht, Lena

AU - Aanaes, Kasper

AU - Kristensen, Elisabeth

AU - Ralfkiaer, Elisabeth M

AU - von Buchwald, Christian

AU - Specht, Lena

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Abstract Conclusion: In this study we found localized malignant lymphomas of the head and neck to be highly treatable and to have a significantly improved prognosis with recent treatment methods. The head and neck surgeon should keep in mind that the prognosis, especially for diffuse large B-cell lymphoma, has improved if the patient receives the optimal treatment. Objectives: The purpose of this study was to ascertain the current prognosis of localized malignant lymphoma of the head and neck given recent advancements in treatment and diagnostic features, as well as adding histological subtypes to the literature according to the 2001 classification. Methods: We present a retrospective study including a cohort of 100 consecutive patients who had localized malignant lymphoma within the head and neck region diagnosed at a single centre from 2000 to 2007. Results: The histology was revised according to the WHO classification and showed 58% with diffuse large B-cell lymphoma. The estimated 5-year overall survival rate was 83%, which should be seen in contrast to survival rates of 40-70% 25 years ago.

AB - Abstract Conclusion: In this study we found localized malignant lymphomas of the head and neck to be highly treatable and to have a significantly improved prognosis with recent treatment methods. The head and neck surgeon should keep in mind that the prognosis, especially for diffuse large B-cell lymphoma, has improved if the patient receives the optimal treatment. Objectives: The purpose of this study was to ascertain the current prognosis of localized malignant lymphoma of the head and neck given recent advancements in treatment and diagnostic features, as well as adding histological subtypes to the literature according to the 2001 classification. Methods: We present a retrospective study including a cohort of 100 consecutive patients who had localized malignant lymphoma within the head and neck region diagnosed at a single centre from 2000 to 2007. Results: The histology was revised according to the WHO classification and showed 58% with diffuse large B-cell lymphoma. The estimated 5-year overall survival rate was 83%, which should be seen in contrast to survival rates of 40-70% 25 years ago.

U2 - 10.3109/00016480903311229

DO - 10.3109/00016480903311229

M3 - Journal article

C2 - 19883174

VL - 130

SP - 626

EP - 631

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 5

ER -

ID: 19253890